Cisatracurium Neuromuscular Blockade Reversal Assessment

Assess cisatracurium reversal readiness using train-of-four (TOF) ratio and guide neostigmine or sugammadex dosing for ICU patients post-neuromuscular blockade for ARDS or status asthmaticus.

Weight
Height
Clinical Guidance

BMI is a screening measure of body size, not a direct measure of body fat. The standard WHO categories are underweight (<18.5), normal (18.5–24.9), overweight (25–29.9), and obese (≥30).

BMI can overestimate body fat in athletes with high muscle mass and underestimate it in older adults with low muscle mass. Interpret it alongside waist circumference and clinical context rather than as a standalone diagnosis.

⚕ Clinical Disclaimer: These calculators are for educational and reference purposes only. Always verify results with qualified clinical judgment and current clinical guidelines. Do not use as a sole basis for medical decisions.
Advertisement

How It Works

Assess cisatracurium reversal readiness using train-of-four (TOF) ratio and guide neostigmine or sugammadex dosing for ICU patients post-neuromuscular blockade for ARDS or status asthmaticus

Each component has a specific meaning:

  • Train-of-four ratio — The train-of-four ratio recorded for the scenario being assessed.
  • Guide neostigmine or sugammadex dosing — The guide neostigmine or sugammadex dosing recorded for the scenario being assessed.

Note: Interpret the cisatracurium reversal result against the thresholds and context described above.

How to Use

Enter the train-of-four ratio, guide neostigmine or sugammadex dosing for the scenario you are assessing. Assess cisatracurium reversal readiness using train-of-four (TOF) ratio and guide neostigmine or sugammadex dosing for ICU patients post-neuromuscular blockade for ARDS or status asthmaticus. Use the cisatracurium reversal result to inform your calculation.

Frequently Asked Questions